Clinical Application of Wearable Ultrasound Sensors
Launched by CHINESE PLA GENERAL HOSPITAL · Jun 6, 2025
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new wearable ultrasound sensor designed to help doctors diagnose and monitor conditions like Deep Vein Thrombosis (DVT) and heart problems more easily and in real-time. The goal is to create a device that patients can wear, which allows for quick and accurate imaging of their health conditions without needing to visit a hospital for tests. This innovative technology could change how we manage various diseases by making monitoring more convenient and efficient.
To participate in this trial, you need to be at least 18 years old and able to give your consent. You'll also need to have a relevant health condition, such as heart failure or confirmed lower-limb DVT, or be in an intensive care unit (ICU) where constant monitoring is needed. If you qualify, you can expect to wear the device for monitoring, which will help researchers understand how well it works. However, certain factors, like skin infections or difficulties in cooperation, may prevent you from joining the study. This trial is currently not recruiting participants, but it represents an exciting step forward in improving patient care through technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 yrs and able to consent
- • Relevant diagnosis for study arm (heart failure, lower-limb DVT, or ICU monitoring)
- • Adequate acoustic window and intact skin at sensor site
- Arm-specific:
- • Heart-failure arm: Clinically stable HFrEF or HFpEF on standard therapy
- • DVT arm: Imaging-confirmed lower-limb DVT, anticoagulated or scheduled for intervention
- • ICU arm: ICU/post-op patient requiring continuous bedside ultrasound
- Exclusion Criteria:
- • Poor acoustic window preventing interpretable images
- • Local skin infection, open wound, or implant/hardware blocking sensor
- • Inability to cooperate with monitoring
- Arm-specific:
- • Heart-failure arm: Acute MI or uncontrolled arrhythmia in past 3 months
- • DVT arm: Active bleeding or severe coagulopathy
- • ICU arm: Unstable multi-organ failure precluding safe monitoring
About Chinese Pla General Hospital
The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Yukun Luo, Professor, M.D.
Principal Investigator
Chinese PLA General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported